The event is an earnings conference call with analysts and investors, scheduled as part of the company's investor engagement activities.
The call is scheduled for Thursday, August 13, 2026, at 04:00 PM Indian Standard Time (IST).
The stated purpose is to discuss the company's financial performance for the quarter ended June 30, 2026 (Q1 FY27).
The management participants will be Mr. Ram Agarwal, Chief Executive Officer and Whole Time Director, and Mr. Abhishek Jain, Chief Financial Officer.
The document does not specify if a presentation, earnings deck, transcript, or recording will be made available.
The intimation is made pursuant to Regulation 30 and 46(2) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The document does not contain any explicit statement regarding the sharing of unpublished price sensitive information (UPSI).
Additional Notes Section
An earnings call invite was enclosed with this regulatory filing, as mentioned in the letter.
The communication is also available on the company's website at www.prostarm.com.
No financial data or figures were disclosed in this announcement.
The call is being coordinated by Arihant Capital Markets Ltd., which provided universal and international dial-in numbers and a DiamondPass registration link for express join.
